Roche announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the...
Novartis announced that the US FDA expanded the indication for Tasigna (nilotinib) to include treatment of first- and second-line pediatric...
GSK announced the start of a phase III study investigating Benlysta (belimumab) in combination with rituximab in adult patients with...
Sanofi and Regeneron Pharmaceuticals, Inc. announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the...
Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces that it has been granted a...
Partners Pharmacy is pleased to announce the acquisition of the Presbyterian Village North (PVN) onsite pharmacy. PVN is a premier...
Fidia Farmaceutici announced the positive results of a Phase II study evaluating the efficacy and tolerability of Oncofid®PB, an innovative...
Biogen Inc. announced that it will present at the Advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting. A...
Best Places to Work program is an international program providing employers in different regions the opportunity to learn more about...
Chemspec Europe has long become the annual get-together of the internationalfine and speciality chemicals industry. For its 33rd edition, the...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
